Company registration number 09254290 (England and Wales)
ALEPSYR BIOTECH CONSULTANCY LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
PAGES FOR FILING WITH REGISTRAR
ALEPSYR BIOTECH CONSULTANCY LTD
BALANCE SHEET
AS AT
31 OCTOBER 2023
31 October 2023
- 1 -
2023
2022
£
£
£
£
Current assets
642,730
579,452
Creditors: amounts falling due within one year
(33,155)
(64,444)
Net current assets
609,575
515,008
Net assets
609,575
515,008
Capital and reserves
609,575
515,008
Notes to the financial statements
1
Reporting period
The current reporting period is 31 October 2016. The comparative accounting reference date was period ended 31 October 2016 was longer then one year due to first set of accounts was prepared.
2
Employees
The average number of persons, including directors, employed by the company during the year was as follows:
2023
2022
Number
Number
Employees
1
1
Alepsyr Biotech Consultancy Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 27 Mulgrave Road, Ealing, London, United Kingdom, W5 1LF.
For the year ended 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
ALEPSYR BIOTECH CONSULTANCY LTD
BALANCE SHEET (CONTINUED)
AS AT
31 OCTOBER 2023
31 October 2023
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 30 July 2024 and are signed on its behalf by:
Dr R Zeitouni
Director
Company registration number 09254290 (England and Wales)